{"aggression": 7.25, "agitation": 2.69, "aphasia": 2.84, "ataxia": 12.37, "atrioventricular block": 7.41, "atrioventricular block complete": 27.44, "atrioventricular block second degree": 23.31, "balance disorder": 2.31, "behaviour disorder": 12.79, "bradycardia": 3.28, "cardiac arrest": 3.74, "cardio-respiratory arrest": 2.69, "cognitive disorder": 6.74, "completed suicide": 2.36, "condition aggravated": 2.96, "diplopia": 13.11, "drug ineffective": 7.0, "drug ineffective for unapproved indication": 8.34, "drug interaction": 5.53, "drug intolerance": 3.75, "drug reaction with eosinophilia and systemic symptoms": 4.02, "drug resistance": 14.7, "electrocardiogram qrs complex prolonged": 25.51, "encephalopathy": 3.83, "epilepsy": 12.47, "exposure during pregcy": 3.18, "focal dyscognitive seizures": 103.18, "foetal exposure during pregcy": 4.44, "generalised tonic-clonic seizure": 16.4, "intentional overdose": 2.67, "irritability": 2.66, "maternal exposure during pregcy": 6.2, "medication error": 3.45, "multiple-drug resistance": 432.63, "myoclonic epilepsy": 40.42, "neurotoxicity": 11.67, "nystagmus": 15.97, "off label use": 4.38, "overdose": 3.29, "partial seizures": 68.78, "petit mal epilepsy": 23.15, "premature delivery": 9.54, "product substitution issue": 8.8, "product use issue": 2.7, "psychotic disorder": 3.26, "sedation": 4.33, "seizure": 20.63, "somnolence": 3.01, "status epilepticus": 108.07, "stevens-johnson syndrome": 4.62, "sudden unexplained death in epilepsy": 110.35, "suicidal ideation": 2.34, "therapeutic product effect incomplete": 5.2, "therapy non-responder": 3.79, "toxic epidermal necrolysis": 4.32, "toxicity to various agents": 4.92, "treatment failure": 4.23, "treatment noncompliance": 3.36, "ventricular tachycardia": 6.42}